At diagnosis, the proportion of patients with renal impairment (creatinine>2 mg/dL), anemia (Hb<10 g/dL), hypercalcemia (Ca>11 mg/dL) and presence of bone lesions were 18%, 36%, 9% and 65%, respectively. This evidence concerns the gene GSTM1 and anemia.